skip to content

Cambridge Stem Cell Institute

 
Read more at: Göttgens Group publishes research on a new model

Göttgens Group publishes research on a new model

8 January 2024

A new collaborative paper from the Göttgens , Kranc and O’Carroll groups reports the first model of homeostatic in vivo tissue dynamics that is anchored in single cell genomics data in the Cell Stem Cell publication out last week (5 January). In time series measurements extending over 9 months, the Kranc Group (Institute...


Read more at: PI Kostas Tzelepis presents at the 65th Annual ASH Conference on STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor
I Kostas Tzelepis presents at the 65th Annual ASH Conference

PI Kostas Tzelepis presents at the 65th Annual ASH Conference on STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor

12 December 2023

On Friday 8 December, CSCI PI Kostantinos Tzelepis presented his research at the Annual American Society of Hematology (ASH) Meeting in San Diego, USA. This presentation focused on the pre-clinical development and characterisation of the first-in-class METTL1 RNA Methyltransferase inhibitor, a totally novel anticancer...


Read more at: CSCI celebrates second annual Christmas Market

CSCI celebrates second annual Christmas Market

11 December 2023

On Friday 1 December, CSCI celebrated our second annual Christmas Market at the Jeffrey Cheah Biomedical Centre . Partnering with our neighbours at Cancer Research UK Cambridge Institute and Cambridge Biomedical Campus , and with volunteers from The Milner Therapeutics Institute and Cambridge Institute of Therapeutic...


Read more at: Dr Alecia-Jane Twigger wins major Fellowship award to establish a Cambridge lactation lab
Dr Alecia-Jane Twigger looking through microscope

Dr Alecia-Jane Twigger wins major Fellowship award to establish a Cambridge lactation lab

4 December 2023

It was announced today that Dr Alecia-Jane Twigger has been awarded a UK Research and Innovation (UKRI) Future Leaders Fellowship. These Fellowships are awarded by UKRI to support universities and businesses in developing their most talented early career researchers and innovators. Dr Twigger, a Research Associate in...


Read more at: Dr Konstantinos Tzelepis named as an Emerging Leader in Leukaemia

Dr Konstantinos Tzelepis named as an Emerging Leader in Leukaemia

25 October 2023

Last week, the journal Leukemia announced CSCI PI Dr Konstantinos Tzelepis as one of three Emerging Leaders in Leukemia. The Nature Publishing Group journal’s Emerging Leaders collection selects rising talent in the field of haematology, providing a spotlight so they can share their work with others. Kostas and his group...


Read more at: Sarah Teichmann elected as Professor in Stem Cell Medicine

Sarah Teichmann elected as Professor in Stem Cell Medicine

18 October 2023

It was announced today (18 October) that Dr Sarah Teichmann and her group will join the Cambridge Stem Cell Institute (CSCI) Sarah will be moving from the Wellcome Sanger Institute , where she has been heading the Cellular Genetics programme. Sarah is a highly distinguished computational biologist, and co-lead of the...


Read more at: CSCI Welcomes Dr Thorsten Boroviak as new Group Leader
Dr Boroviak joins CSCI

CSCI Welcomes Dr Thorsten Boroviak as new Group Leader

10 October 2023

Dr Thorsten Boroviak joins us this month (from 1 October) as a Principal Investigator researching primate embryogenesis. Dr Boroviak joins us from the Department of Physiology, Development and Neuroscience at University of Cambridge. CSCI Director Bertie Göttgens comments on Dr Boroviak's appointment: "I am very happy to...


Read more at: Sinha Lab to receive one of four new BBSRC sLoLa grants

Sinha Lab to receive one of four new BBSRC sLoLa grants

29 September 2023

Professor Sanjay Sinha and his team have just been announced (28 September) as one of the four world-class teams to receive a share of £18 million to pursue transformational bioscience research programmes. The four teams will tackle bold challenges at the frontiers of bioscience, combining world-class ideas, people and...


Read more at: Philpott Lab discovery could lead to 'kinder' treatment for neuroblastoma
Ball of neuroblastoma cells forming mature nerves after drug treatment (Credit: Kirsty Ferguson/Developmental Cell)

Philpott Lab discovery could lead to 'kinder' treatment for neuroblastoma

20 September 2023

Neuroblastoma is responsible for 15% of cancer deaths in children. Research out today from the Philpott Lab offers hope to these children, who could in future be given treatments with fewer side-effects than those associated with the current chemotherapy. The approach involves the use of a ‘differentiation therapy’, a type...


Read more at: SKAN Research Trust and Wellcome-MRC Cambridge Stem Cell Institute to collaborate in stem cell research
Group photo of SKAN-CSCI

SKAN Research Trust and Wellcome-MRC Cambridge Stem Cell Institute to collaborate in stem cell research

6 September 2023

Today (6 September) the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) welcomed Indian entrepreneur Ashok Soota from SKAN Research Trust (SKAN) to Cambridge to mark an upcoming partnership between the two organisations that will bring cutting edge expertise in stem cell research to India. SKAN (an acronym for Scientific...